FF — Fine Foods & Pharmaceuticals NTM SpA Cashflow Statement
0.000.00%
Last trade - 00:00- €191.24m
- €239.13m
- €252.06m
Annual cashflow statement for Fine Foods & Pharmaceuticals NTM SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.43 | -9.5 | -3.52 | 8.16 | 10.1 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 11.9 | 14.6 | 8.25 | 5.6 | 7.42 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -27.8 | -12.2 | -4.1 | 13.5 | -5.47 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.83 | 3.69 | 18.5 | 45.9 | 31.8 |
| Capital Expenditures | -15.9 | -16 | -18.9 | -34.7 | -36 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -20.4 | 0.67 | 64.8 | 3.17 | 0.15 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -36.3 | -15.3 | 45.9 | -31.6 | -35.8 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 56 | 4.74 | -55.7 | -14.1 | 23.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13.8 | -6.89 | 8.77 | 0.21 | 19.7 |